Triumpharma Clinical Research Unit at AlEssra Hospital
Amman, Jordan
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting
Phase 1
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)
LAPIX Therapeutics Inc.48 enrolled1 locationNCT06628206